Meredith Cook is CLO & VP +1 at ANI PHARMACEUTICALS INC (ANIP). They have made 1 open-market trade across 1 company since 2023, most recently 2026-10-13.
CIK 0001938861
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANIP | 73,424 | $5.3M |
Shares reported on the most recent Form 4, priced at the 2026-10-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANIP | SELL · 10b5-1 | 2026-10-13 | 2026-10-13 | $73.59 | $37K | — | — | — |
| ANIP | SELL · 10b5-1 | 2026-09-14 | 2026-09-14 | $70.79 | $35K | +5.3% | -0.4% | — |
| ANIP | SELL · 10b5-1 | 2026-08-13 | 2026-08-13 | $75.48 | $38K | +2.3% | -4.9% | — |
| ANIP | SELL · 10b5-1 | 2026-07-13 | 2026-07-14 | $81.84 | $41K | -3.5% | -7.0% | -8.5% |
| ANIP | SELL · 10b5-1 | 2026-06-12 | 2026-06-15 | $82.03 | $41K | +2.4% | -1.8% | -14.6% |
| ANIP | SELL · 10b5-1 | 2026-05-13 | 2026-05-13 | $78.16 | $39K | -0.3% | -0.0% | -8.5% |
| ANIP | SELL · 10b5-1 | 2026-04-13 | 2026-04-13 | $77.95 | $39K | -0.2% | +3.4% | +3.8% |
| ANIP | SELL | 2026-03-13 | 2026-03-13 | $72.62 | $36K | +4.7% | +10.7% | +15.5% |
| ANIP | SELL · 10b5-1 | 2026-02-13 | 2026-02-17 | $76.80 | $38K | -6.3% | -5.1% | +0.4% |
| ANIP | SELL · 10b5-1 | 2026-01-13 | 2026-01-14 | $84.33 | $42K | -5.0% | -8.7% | -7.6% |
| ANIP | SELL · 10b5-1 | 2025-12-12 | 2025-12-12 | $82.32 | $33K | +1.3% | +4.0% | -10.6% |
| ANIP | SELL · 10b5-1 | 2025-11-13 | 2025-11-14 | $87.27 | $35K | +0.2% | -3.2% | -8.9% |
| ANIP | SELL · 10b5-1 | 2025-10-13 | 2025-10-14 | $90.09 | $36K | +6.0% | -4.9% | -5.1% |
| ANIP | SELL · 10b5-1 | 2025-09-12 | 2025-09-15 | $98.42 | $39K | -5.6% | -8.9% | -17.6% |
| ANIP | SELL · 10b5-1 | 2025-08-13 | 2025-08-14 | $88.87 | $36K | +3.9% | +11.7% | -1.4% |
| ANIP | SELL · 10b5-1 | 2025-07-14 | 2025-07-14 | $64.88 | $26K | +2.6% | +36.3% | +36.1% |
| ANIP | SELL · 10b5-1 | 2025-06-13 | 2025-06-16 | $61.37 | $25K | +3.0% | +4.7% | +55.3% |
| ANIP | SELL · 10b5-1 | 2025-05-13 | 2025-05-13 | $62.20 | $25K | -7.1% | -0.2% | +36.4% |
| ANIP | SELL · 10b5-1 | 2025-04-14 | 2025-04-14 | $68.96 | $28K | +2.1% | -11.7% | -4.7% |
| ANIP | SELL · 10b5-1 | 2025-03-13 | 2025-03-14 | $63.33 | $25K | +6.9% | +9.4% | -1.1% |
| ANIP | SELL · 10b5-1 | 2025-02-13 | 2025-02-18 | $59.54 | $24K | +5.5% | +9.6% | +2.5% |
| ANIP | SELL · 10b5-1 | 2025-01-13 | 2025-01-13 | $53.92 | $22K | +8.4% | +10.3% | +27.0% |
| ANIP | SELL · 10b5-1 | 2024-12-13 | 2024-12-16 | $56.24 | $14K | -3.2% | +0.6% | +14.5% |
| ANIP | SELL · 10b5-1 | 2024-11-13 | 2024-11-14 | $61.36 | $15K | -1.9% | -4.5% | +1.2% |
| ANIP | SELL · 10b5-1 | 2024-10-14 | 2024-10-15 | $57.19 | $14K | -0.8% | +0.2% | -8.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.